SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-136931
Filing Date
2019-05-03
Accepted
2019-05-03 16:06:03
Documents
7
Period of Report
2019-04-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d733314d8k.htm 8-K 22383
2 EX-10.1 d733314dex101.htm EX-10.1 42691
3 GRAPHIC g733314g12n30.jpg GRAPHIC 73308
4 GRAPHIC g733314g21n82.jpg GRAPHIC 134419
5 GRAPHIC g733314g34m79.jpg GRAPHIC 68754
6 GRAPHIC g733314g86s07.jpg GRAPHIC 146514
7 GRAPHIC g733314g99f54.jpg GRAPHIC 47921
  Complete submission text file 0001193125-19-136931.txt   715639
Mailing Address 500 TOTTEN POND ROAD WALTHAM MA 02451
Business Address 500 TOTTEN POND ROAD WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 19796143
SIC: 2834 Pharmaceutical Preparations